Zhifei Biological (300122.SZ) released its first three quarters performance, with a net loss attributable to shareholders of RMB 683 million.

Zhitong Finance APP News, Zhifei Biological (300122.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 6.539 billion yuan, a year-on-year decrease of 14.46%. The net loss attributable to shareholders of the listed company was 683 million yuan. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 687 million yuan.